Overview

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer

Status:
Completed

Trial end date:
2001-02-01

Target enrollment:

Participant gender:

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug with peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy plus peripheral stem cell transplantation in treating patients with stage III or stage IV ovarian epithelial cancer.

Phase:

Phase 2

Details

Lead Sponsor:

University of Maryland
University of Maryland, Baltimore

Collaborator:

University of Maryland Greenebaum Cancer Center

Treatments:

Carmustine
Melphalan
Paclitaxel